GQ1001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GQ1001, covering 2024-02-26 to 2024-02-26. Get the full timeline:
Most recent: Clinical Trial Update: GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer [Phase 1, Phase 2]